Native antigens are extracted in their natural form from the respective sources. As they undergo usual modifications in vivo, upon isolation, they exhibit close resemblance withthe complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications may include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation.
This report contains market size and forecasts of Native Bacterial and Viral Antigens in Global, including the following market information:
Global Native Bacterial and Viral Antigens Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Native Bacterial and Viral Antigens market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chlamydia Antigens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Native Bacterial and Viral Antigens include BIO-RAD LABORATORIES INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd, Enzo Life Sciences Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company and Creative Diagnostics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Native Bacterial and Viral Antigens companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Native Bacterial and Viral Antigens Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Native Bacterial and Viral Antigens Market Segment Percentages, by Type, 2021 (%)
Chlamydia Antigens
Adenovirus Antigens
Borrelia Antigens
Chikungunya Virus Antigens
Clostridium Antigens
Dengue Virus Antigens
Global Native Bacterial and Viral Antigens Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Native Bacterial and Viral Antigens Market Segment Percentages, by Application, 2021 (%)
ELISA
Immunoassay
SDS-PAGE
Hemagglutination
Agglutination Test
Global Native Bacterial and Viral Antigens Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Native Bacterial and Viral Antigens Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Native Bacterial and Viral Antigens revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Native Bacterial and Viral Antigens revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BIO-RAD LABORATORIES INC.
Microbix Biosystems
SERION Immunologics
Aalto Bio Reagents Ltd
Enzo Life Sciences Inc.
Jena Bioscience GmbH
ROSS SOUTHERN LABORATORIES
The Native Antigen Company
Creative Diagnostics
TRINA BIOREACTIVES AG